Ladanifer The US FDA has granted Fast Track designation to KT-621, a potential first-in-class oral...
KYMR
Comments Kymera Therapeutics (NASDAQ:KYMR) stated on Monday that it has commenced an underwritten public offering...
Ladanifer The US FDA has granted Fast Track designation to KT-621, a potential first-in-class oral...
Comments Kymera Therapeutics (NASDAQ:KYMR) stated on Monday that it has commenced an underwritten public offering...